Assessment of cerebral blood volume in schizophrenia: A magnetic resonance imaging study

Journal of Psychiatric Research

Volumn 41, Issue 6, 2007, Pages 502-510

  Brambilla, Paolo ^a   Cerini, Roberto ^b   Fabene, Paolo F ^b   Andreone, Nicola ^b   Rambaldelli, Gianluca ^b   Farace, Paolo ^b   Versace, Amelia ^b   Perlini, Cinzia ^b   Pelizza, Luisa ^b   Gasparini, Anna ^b   Gatti, Rachele ^b,c   Bellani, Marcella ^b   Dusi, Nicola ^b   Barbui, Corrado ^b   Nosè, Michela ^b   Tournikioti, Kalliopi ^b   Sbarbati, Andrea ^b   Tansella, Michele ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Brain; Gadolinium; Neuroimaging; NMR; Perfusion; Vascular organization

Indexed keywords

CHLORPROMAZINE; CLOTIAPINE; CLOZAPINE; FLUPHENAZINE; FREE RADICAL; GADOLINIUM PENTETATE; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD VOLUME; BRAIN SIZE; BRAIN SLICE; CALCULATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHO PLANAR IMAGING; FEMALE; HEMISPHERE; HEMISPHERIC DOMINANCE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THICKNESS;

ADULT; ATROPHY; BRAIN; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; FUNCTIONAL LATERALITY; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33846891116     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.03.002     Document Type: Article

References (69)

1. Amaddeo F., Beecham J., Bonizzato P., Fenyo A., Knapp M., and Tansella M. The use of a case register to evaluate the costs of psychiatric care. Acta Psychiatr Scand 95 (1997) 189-198
2. Andreasen N.C., Rezai K., Alliger R., Swayze II V.W., Flaum M., Kirchner P., et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 49 (1992) 943-958
3. Bennett S.A., Tenniswood M., Chen J.H., Davidson C.M., Keyes M.T., Fortin T., et al. Chronic cerebral hypoperfusion elicits neuronal apoptosis and behavioral impairment. Neuroreport 9 (1998) 161-166
4. Berchtenbreiter C., Bruening R., Wu R.H., Penzkofer H., Weber J., and Reiser M. Comparison of the diagnostic information in relative cerebral blood volume, maximum concentration, and subtraction signal intensity maps based on magnetic resonance imaging of gliomas. Invest Radiol 34 (1999) 75-81
5. Breitner J.C., Husain M.M., Figiel G.S., Krishnan K.R., and Boyko O.B. Cerebral white matter disease in late-onset paranoid psychosis. Biol Psychiatry 28 (1990) 266-274
6. Brockington A., Lewis C., Wharton S., and Shaw P.J. Vascular endothelial growth factor and the nervous system. Neuropathol Appl Neurobiol 30 (2004) 427-446
7. Bushe C., Haddad P., Peveler R., and Pendlebury J. The role of lifestyle interventions and weight management in schizophrenia. J Psychopharmacol 19 (2005) 28-35
8. Cannon T.D., van Erp T.G., Huttunen M., Lonnqvist J., Salonen O., Valanne L., et al. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 55 (1998) 1084-1091
9. Cha S., Lu S., Johnson G., and Knopp E.A. Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging 11 (2000) 114-119
10. Derex L., Hermier M., Adeleine P., Pialat J.B., Wiart M., Berthezene Y., et al. Influence of the site of arterial occlusion on multiple baseline hemodynamic MRI parameters and post-thrombolytic recanalization in acute stroke. Neuroradiology 46 (2004) 883-887
11. *-weighted MR imaging at 1.5 T. Radiology 176 (1990) 211-220
12. Erbas B., Kumbasar H., Erbengi G., and Bekdik C. Tc-99m HMPAO/SPECT determination of regional cerebral blood flow changes in schizophrenics. Clin Nucl Med 15 (1990) 904-907
13. Farkas E., Donka G., de Vos R.A., Mihaly A., Bari F., and Luiten P.G. Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol (Berl) 108 (2004) 57-64
14. Fernandes S.R., Coimbra I.B., Costallat L.T., and Ribeiro Filho J.E. Uncommon features of polyarteritis nodosa: psychosis and angio-oedema. Clin Rheumatol 17 (1998) 353-356
15. Gilbert A.R., Montrose D.M., Sahni S.D., Diwadkar V.A., and Keshavan M.S. Obstetric complications correlate with neurobehavioral and brain structural alterations in young relatives at risk for schizophrenia. Ann N Y Acad Sci 1008 (2003) 269-275
16. Goff D.C., Sullivan L.M., McEvoy J.P., Meyer J.M., Nasrallah H.A., Daumit G.L., et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res 80 (2005) 45-53
17. Gonul A.S., Kula M., Esel E., Tutus A., and Sofuoglu S. A Tc-99m HMPAO SPECT study of regional cerebral blood flow in drug-free schizophrenic patients with deficit and non-deficit syndrome. Psychiatry Res 123 (2003) 199-205
18. Gonul A.S., Kula M., Sofuoglu S., Tutus A., and Esel E. Tc-99 HMPAO SPECT study of regional cerebral blood flow in olanzapine-treated schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 253 (2003) 29-33
19. Gur R.E., Skolnick B.E., Gur R.C., Caroff S., Rieger W., Obrist W.D., et al. Brain function in psychiatric disorders. I. Regional cerebral blood flow in medicated schizophrenics. Arch Gen Psychiatry 40 (1983) 1250-1254
20. Hafner H. Schizophrenia: still Kraepelin's Dementia Praecox?. Epidemiol Psichiatr Soc 13 (2004) 99-112
21. Hai J., Ding M., Guo Z., and Wang B. A new rat model of chronic cerebral hypoperfusion associated with arteriovenous malformations. J Neurosurg 97 (2002) 1198-1202
22. Hanson D.R., and Gottesman I.I. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Genet 6 (2005) 7
23. Harrison G. Trajectories of psychosis: towards a new social biology of schizophrenia. Epidemiol Psichiatr Soc 13 (2004) 152-157
24. Henderson D.C., Nguyen D.D., Copeland P.M., Hayden D.L., Borba C.P., Louie P.M., et al. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. J Clin Psychiatry 66 (2005) 1116-1121
25. Hess D.C. Cerebral lupus vasculopathy. Mechanisms and clinical relevance. Ann N Y Acad Sci 823 (1997) 154-168
26. Higashima M., Kawasaki Y., Urata K., Sakai N., Nagasawa T., Koshino Y., et al. Regional cerebral blood flow in male schizophrenic patients performing an auditory discrimination task. Schizophr Res 42 (2000) 29-39
27. Jibiki I., Matsuda H., Yamaguchi N., Kurokawa K., and Hisada K. Acutely administered haloperidol-induced pattern changes of regional cerebral blood flow in schizophrenics. Observation from subtraction of brain imaging with single photon emission computed tomography using technetium-99m hexamethyl-propyleneamine oxime. Neuropsychobiology 25 (1992) 182-187
28. Kasparova S., Brezova V., Valko M., Horecky J., Mlynarik V., Liptaj T., et al. Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem Int 46 (2005) 601-611
29. Keshavan M.S., Diwadkar V.A., and Rosenberg D.R. Developmental biomarkers in schizophrenia and other psychiatric disorders: Common origins, different trajectories?. Epidemiol Psichiatr Soc 14 (2005) 188-193
30. Lass P., Krajka-Lauer J., Homziuk M., Iwaszkiewicz-Bilikiewicz B., Koseda M., Hebanowski M., et al. Cerebral blood flow in Sjogren's syndrome using 99Tcm-HMPAO brain SPET. Nucl Med Commun 21 (2000) 31-35
31. Lim K.O., Sullivan E.V., Zipursky R.B., and Pfefferbaum A. Cortical gray matter volume deficits in schizophrenia: a replication. Schizophr Res 20 (1996) 157-164
32. Liu Y.J., Chung H.W., Huang I.J., Wang F.N., Chin S.C., Lee C.S., et al. A reinvestigation of maximal signal drop in dynamic susceptibility contrast magnetic resonance imaging. J Neuroimag 12 (2002) 330-338
33. Matsuda H., Jibiki I., Kinuya K., Kinuya S., Shuke N., Sumiya H., et al. Tc-99m HMPAO SPECT analysis of neuroleptic effects on regional brain function. Clin Nucl Med 16 (1991) 660-664
34. Meroni P.L., Tincani A., Sepp N., Raschi E., Testoni C., Corsini E., et al. Endothelium and the brain in CNS lupus. Lupus 12 (2003) 919-928
35. Miller D.D., Rezai K., Alliger R., and Andreasen N.C. The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography. Biol Psychiatry 41 (1997) 550-559
36. Molina Rodriguez V., Montz Andree R., Perez Castejon M.J., Capdevila Garcia E., Carreras Delgado J.L., and Rubia Vila F.J. SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine. Am J Psychiatry 153 (1996) 1343-1346
37. Molina Rodriguez V., Montz Andree R., Perez Castejon M.J., Gutierrez Labrador R., Ferre Navarrete F., Carreas Delgado J.L., et al. Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study. Schizophr Res 25 (1997) 11-20
38. Ni J.W., Matsumoto K., Li H.B., Murakami Y., and Watanabe H. Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res 673 (1995) 290-296
39. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 9 (1971) 97-113
40. Paradiso S., Andreasen N.C., Crespo-Facorro B., O'Leary D.S., Watkins G.L., Boles Ponto L.L., et al. Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am J Psychiatry 160 (2003) 1775-1783
41. Rosen B.R., Belliveau J.W., Vevea J.M., and Brady T.J. Perfusion imaging with NMR contrast agents. Magn Reson Med 14 (1990) 249-265
42. Rosen B.R., Belliveau J.W., Aronen H.J., Kennedy D., Buchbinder B.R., Fischman A., et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 22 (1991) 293-299 discussion 300-3
43. Russell J.M., Early T.S., Patterson J.C., Martin J.L., Villanueva-Meyer J., and McGee M.D. Temporal lobe perfusion asymmetries in schizophrenia. J Nucl Med 38 (1997) 607-612
44. Sachdev P., and Brodaty H. Quantitative study of signal hyperintensities on T2-weighted magnetic resonance imaging in late-onset schizophrenia. Am J Psychiatry 156 (1999) 1958-1967
45. Sachdev P., Brodaty H., Rose N., and Haindl W. Regional cerebral blood flow in late-onset schizophrenia: a SPECT study using 99mTc-HMPAO. Schizophr Res 27 (1997) 105-117
46. Sekhon L.H., Morgan M.K., Spence I., and Weber N.C. Chronic cerebral hypoperfusion: pathological and behavioral consequences. Neurosurgery 40 (1997) 548-556
47. Shenton M.E., Dickey C.C., Frumin M., and McCarley R.W. A review of MRI findings in schizophrenia. Schizophr Res 49 (2001) 1-52
48. Shinba T., Nagano M., Kariya N., Ogawa K., Shinozaki T., Shimosato S., et al. Near-infrared spectroscopy analysis of frontal lobe dysfunction in schizophrenia. Biol Psychiatry 55 (2004) 154-164
49. Strassnig M., Brar J.S., and Ganguli R. Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia. Schizophr Res 75 (2005) 425-432
50. Tanaka K., Wada-Tanaka N., Miyazaki I., Nomura M., and Ogawa N. Chronic cerebral hypoperfusion induces striatal alterations due to the transient increase of NO production and the depression of glutathione content. Neurochem Res 27 (2002) 331-336
51. Tansella M., and Burti L. Integrating evaluative research and community-based mental health care in Verona, Italy. Br J Psychiatry 183 (2003) 167-169
52. Tomimoto H., Ihara M., Wakita H., Ohtani R., Lin J.X., Akiguchi I., et al. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol (Berl) 106 (2003) 527-534
53. Tonkonogy J.M., and Geller J.L. Late-onset paranoid psychosis as a distinct clinicopathologic entity: magnetic resonance imaging data in elderly patients with paranoid psychosis of late onset and schizophrenia of early onset. Neuropsychiatry Neuropsychol Behav Neurol 12 (1999) 230-235
54. Valentini V., Gaudino S., Spagnolo P., Armenise S., Tartaglione T., and Marano P. Diffusion and perfusion MR imaging. Rays 28 (2003) 29-43
55. Ventura J., Nuechterlein K.H., Subotnik K.L., Gutkind D., and Gilbert E.A. Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item brief psychiatric rating scale. Psychiatry Res 97 (2000) 129-135
56. Vita A., Bressi S., Perani D., Invernizzi G., Giobbio G.M., Dieci M., et al. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. Am J Psychiatry 152 (1995) 876-882
57. Volz H.P., Rzanny R., Rossger G., Hubner G., Kreitschmann-Andermahr I., Kaiser W.A., et al. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics - a study including 50 patients and 36 controls. Biol Psychiatry 44 (1998) 399-404
58. Volz H., Gaser C., Hager F., Rzanny R., Ponisch J., Mentzel H., et al. Decreased frontal activation in schizophrenics during stimulation with the continuous performance test - a functional magnetic resonance imaging study. Eur Psychiatry 14 (1999) 17-24
59. Volz H.R., Riehemann S., Maurer I., Smesny S., Sommer M., Rzanny R., et al. Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study. Biol Psychiatry 47 (2000) 954-961
60. Webster M.J., Knable M.B., Johnston-Wilson N., Nagata K., Inagaki M., and Yolken R.H. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immunol 15 (2001) 388-400
61. Webster M.J., O'Grady J., Kleinman J.E., and Weickert C.S. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 133 (2005) 453-461
62. Wing J.K., Babor T., Brugha T., Burke J., Cooper J.E., Giel R., et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 47 (1990) 589-593
63. Wood S.J., Yücel M., Yung A.R., Berger G.E., Velakoulis D., and Pantelis C. The transition to psychosis: risk factors and brain changes. Epidemiol Psichiatr Soc 13 (2004) 137-140
64. World Health Organization. Schedules for Clinical Assessment in Neuropsychiatry. In: Wing JK, Series editor. Geneva: WHO, 1992.
65. World Health Organization. Schede di valutazione clinica in neuropsichiatria. SCAN 2.1. In: Tansella M, Nardini M, Series editors. Roma: Il Pensiero Scientifico Editore, 1996.
66. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., and Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157 (2000) 16-25
67. Yacubian J., de Castro C.C., Ometto M., Barbosa E., de Camargo C.P., Tavares H., et al. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophr Res 58 (2002) 117-122
68. Yildiz A., Eryilmaz M., Gungor F., Erkilic M., and Karayalcin B. Regional cerebral blood flow in schizophrenia before and after neuroleptic medication. Nucl Med Commun 21 (2000) 1113-1118
69. Zipursky R.B., Lambe E.K., Kapur S., and Mikulis D.J. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry 55 (1998) 540-546